Safety of Autologous Umbilical Cord Blood Therapy for Acquired Sensorineural Hearing Loss in Children

2018 
This article presents the results of a phase 1 clinical trial to evaluate the intravenous administration of human umbilical cord blood (hUCB) mononuclear fraction in infants and children with acquired sensorineural hearing loss (SNHL).
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    27
    References
    9
    Citations
    NaN
    KQI
    []